[PDF][PDF] Selling stem cells in the USA: assessing the direct-to-consumer industry
L Turner, P Knoepfler - Cell stem cell, 2016 - cell.com
Cell stem cell, 2016•cell.com
Direct-to-consumer marketing of unapproved stem cell interventions is a well-known
phenomenon in countries with lax medical regulations. However, an examination of Internet-
based marketing claims revealed widespread promotion of such interventions by
businesses based in the United States. Such commercial activity suggests that regulatory
agencies must better oversee this marketplace.
phenomenon in countries with lax medical regulations. However, an examination of Internet-
based marketing claims revealed widespread promotion of such interventions by
businesses based in the United States. Such commercial activity suggests that regulatory
agencies must better oversee this marketplace.
Direct-to-consumer marketing of unapproved stem cell interventions is a well-known phenomenon in countries with lax medical regulations. However, an examination of Internet-based marketing claims revealed widespread promotion of such interventions by businesses based in the United States. Such commercial activity suggests that regulatory agencies must better oversee this marketplace.
cell.com